Literature DB >> 15662528

Dramatic development of severe SLE in a patient with an incomplete disease.

G Fabio1, M Carrabba, C Hu, M Floriani, C Besana.   

Abstract

This case report describes the previously-unreported clinical course of a patient with a so-called incomplete systemic lupus erythematosus (SLE), i.e. symptoms related to one organ system only, together with the presence of ANA. He had an indolent course initially and developed, 6 months after the first symptoms, a severe disease with rapid appearance of major and unusual manifestations. The possibility of fast progression and a grave course of an incomplete SLE should be kept in mind. This report is meant to heighten awareness of such an atypical presentation so that prompt and aggressive immunosuppressive therapy may be instituted.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15662528     DOI: 10.1007/s00296-004-0550-1

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  20 in total

1.  A case of testicular lupus.

Authors:  G Walker; P Merry; K Sethia; R Y Ball
Journal:  Lupus       Date:  2000       Impact factor: 2.911

2.  Achalasia, angioedema and systemic lupus erythematosus.

Authors:  C Hidalgo-Tenorio; J M Sabio; L Jaimez; J Jiménez-Alonso
Journal:  Lupus       Date:  2001       Impact factor: 2.911

3.  A particularly private pain.

Authors:  Ursula Göbel; Ralph Kettritz; Wolfgang Schneider; Friedrich C Luft
Journal:  Nephrol Dial Transplant       Date:  2002-03       Impact factor: 5.992

4.  Incomplete lupus erythematosus: results of a multicentre study under the supervision of the EULAR Standing Committee on International Clinical Studies Including Therapeutic Trials (ESCISIT).

Authors:  A J Swaak; H van de Brink ; R J Smeenk; K Manger; J R Kalden; S Tosi; A Marchesoni; Z Domljan; B Rozman; D Logar; G Pokorny; L Kovacs; A Kovacs; P G Vlachoyiannopoulos; H M Moutsopoulos; H Chwalinska-Sadowska; B Dratwianka; E Kiss; N Cikes; B Anic; M Schneider; R Fischer; S Bombardieri; M Mosca; W Graninger; J S Smolen
Journal:  Rheumatology (Oxford)       Date:  2001-01       Impact factor: 7.580

5.  Interstitial cystitis and ileus in pediatric-onset systemic lupus erythematosus.

Authors:  H Tanaka; S Waga; T Tateyama; T Nakahata; T Ito; K Sugimoto; Y Kakizaki; K Tomimoto; M Yokoyama
Journal:  Pediatr Nephrol       Date:  2000-08       Impact factor: 3.714

6.  A new type of acquired C1 inhibitor deficiency associated with systemic lupus erythematosus.

Authors:  P Cacoub; V Frémeaux-Bacchi; I De Lacroix; F Guillien; M F Kahn; M D Kazatchkine; P Godeau; J C Piette
Journal:  Arthritis Rheum       Date:  2001-08

7.  Hyperhomocysteinaemia and risk of thrombosis in systemic lupus erythematosus patients.

Authors:  T M K Refai; I H Al-Salem; D Nkansa-Dwamena; M H Al-Salem
Journal:  Clin Rheumatol       Date:  2002-11       Impact factor: 2.980

Review 8.  Successful treatment of gastrointestinal vasculitis due to systemic lupus erythematosus with intravenous pulse cyclophosphamide: a clinical case report and review of the literature.

Authors:  B Grimbacher; M Huber; J von Kempis; P Kalden; M Uhl; G Köhler; H E Blum; H H Peter
Journal:  Br J Rheumatol       Date:  1998-09

9.  Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants.

Authors:  H I Glueck; K S Kant; M A Weiss; V E Pollak; M A Miller; M Coots
Journal:  Arch Intern Med       Date:  1985-08

10.  Acquired C1 inhibitor deficiency revealing systemic lupus erythematosus.

Authors:  S Ochonisky; L Intrator; J Wechsler; J Revuz; M Bagot
Journal:  Dermatology       Date:  1993       Impact factor: 5.366

View more
  5 in total

1.  Organ damage in patients with incomplete lupus syndromes: from a Chinese academic center.

Authors:  Zhen Chen; Meng-Tao Li; Dong Xu; Xiao-Mei Leng; Qian Wang; Xin-Ping Tian; Shang-Zhu Zhang; Yan Zhao; Xiao-Feng Zeng
Journal:  Clin Rheumatol       Date:  2015-02-18       Impact factor: 2.980

Review 2.  Preclinical lupus.

Authors:  Rebecka Bourn; Judith A James
Journal:  Curr Opin Rheumatol       Date:  2015-09       Impact factor: 5.006

3.  Interferon signature gene expression is correlated with autoantibody profiles in patients with incomplete lupus syndromes.

Authors:  Q-Z Li; J Zhou; Y Lian; B Zhang; V K Branch; F Carr-Johnson; D R Karp; C Mohan; E K Wakeland; N J Olsen
Journal:  Clin Exp Immunol       Date:  2009-12-01       Impact factor: 4.330

4.  Schizophrenia or Atypical Lupus Erythematosus with Predominant Psychiatric Manifestations over 25 Years: Case Analysis and Review.

Authors:  Axel Mack; Christiane Pfeiffer; E Marion Schneider; Karl Bechter
Journal:  Front Psychiatry       Date:  2017-07-27       Impact factor: 4.157

5.  Autoantibody profiling to follow evolution of lupus syndromes.

Authors:  Nancy J Olsen; Quan-Zhen Li; Jiexia Quan; Ling Wang; Azza Mutwally; David R Karp
Journal:  Arthritis Res Ther       Date:  2012-07-27       Impact factor: 5.156

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.